William D. Schwieterman

Statistics

Publications

Citations

4.4K

H-Index

Active since

1987

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Center for Biologics Evaluation and Research

William D. Schwieterman is an author at Icahn School of Medicine at Mount Sinai specializing in rheumatoid arthritis pharmacotherapy, rheumatology, and pharmacotherapy.

Publications per year

1987–2002

Publications

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · New England Journal of Medicine · 2001 · 3.7K citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept

Jong‐Hoon Lee, Nancy R. Slifman, Sharon K. Gershon et al. · Arthritis & Rheumatism · 2002 · 448 citations

Medicine, Immunology, Pharmacotherapy +10

Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut.

William D. Schwieterman, Dario Sorrentino, Barry J. Potter et al. · Proceedings of the National Academy of Sciences · 1988 · 165 citations · Full text

Life Sciences, Biochemistry, Cell Biology +14

Isolation and partial characterization of plasma membrane fatty acid binding proteins from myocardium and adipose tissue and their relationship to analogous proteins in liver and gut

Barry J. Potter, Decherd Stump, William D. Schwieterman et al. · Biochemical and Biophysical Research Communications · 1987 · 54 citations

Life Sciences, Biochemistry, Physiology +12

1–4 of 4